Bionik Laboratories Corp Share Price OTC Bulletin Board
Equities
US09074A1097
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Sales 2022 | 1.27M 97.94M | Sales 2023 | 1.81M 139M | Capitalization | 2.8M 215M |
---|---|---|---|---|---|
Net income 2022 | -10M -769M | Net income 2023 | -4M -308M | EV / Sales 2022 | 0.17 x |
Net cash position 2022 | 1.99M 153M | Net Debt 2023 | 1.98M 153M | EV / Sales 2023 | 2.65 x |
P/E ratio 2022 |
-0.21
x | P/E ratio 2023 |
-0.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 44 | 29/11/20 |
Michal Prywata
FOU | Founder | 33 | 07/01/10 |
Dan Gonsalves
DFI | Director of Finance/CFO | - | 31/08/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Prywata
FOU | Founder | 33 | 07/01/10 |
Director/Board Member | 68 | 31/08/17 | |
Richard Russo
CEO | Chief Executive Officer | 44 | 29/11/20 |
1st Jan change | Capi. | |
---|---|---|
-4.40% | 179B | |
-1.95% | 100B | |
-6.56% | 46.16B | |
+18.16% | 44.81B | |
+9.77% | 44.38B | |
+14.05% | 29.53B | |
+22.31% | 25.83B | |
-7.07% | 23.97B | |
+3.74% | 22.5B |